22 drugs stopped selling in Vietnam
The Drug Administration of Vietnam has decided to withdraw the registration certificates of 22 drugs from the list of drugs granted registration certificates for circulation in Vietnam.
 |
| Excerpt from the list of drugs discontinued from circulation in Vietnam by the Ministry of Health. |
On June 21, Mr. Do Van Dong - Deputy Director of the Department of Drug Administration (Ministry of Health) signed a Decision to withdraw the circulation registration certificates of 22 types of drugs belonging to 6 registration and production establishments from the list of drugs granted circulation registration certificates in Vietnam because the drug registration establishments do not have business needs.
Including Oplatin infusion solution of Reliv pharma Co., Ltd. (HCMC), Rustatin film-coated tablets of Korea United Pharm. Int'l Joint Stock Company; Medphatobra injection solution of Phuong Dai Pharmaceutical Co., Ltd.; Copegus film-coated tablets of F.Hoffmann-La Roche Ltd.; Bondronat film-coated tablets of Productos Roche SAde CV; Loperamide 2mg hard capsules of Glaxomithkline Pte. Ltd.; 2 products of Kujjie Pharma Inc.; 6 products of Hutecs Korrea Pharmaceutical....
The Drug Administration of Vietnam requires that drug registration establishments and manufacturers of these drugs must be responsible for monitoring and taking responsibility for the quality, safety, and effectiveness of the drugs during circulation until the expiration date of the drugs for which the registration certificate for circulation has been withdrawn and which were manufactured or imported before June 21, 2018.